Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Plaque Subcommittee meeting

This article was originally published in The Tan Sheet

Executive Summary

Plaque Subcommittee meeting: The FDA Dental Products Panel Plaque Subcommittee will meet June 6-7 to continue its discussion of the alcohol content of mouthwashes and its review of ingredients, including hydrogen peroxide, sodium bicarbonate, the combination of the two ingredients, and sanguinaria. The subcommittee also will begin to discuss sodium lauryl sulfate. A background document on the possible relationship between alcohol content and mouthwashes is being made available by the agency prior to the meeting. The meeting will be held from 8 a.m. to 5 p.m. both days in the Goshen Room of the Holiday Inn, Gaithersburg, Md. Each day will begin with an open public hearing. Those interested in making a presentation are requested to contact FDA by May 26...

You may also be interested in...



Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

UsernamePublicRestriction

Register

ID007083

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel